Increases in the number of cancer cases being diagnosed and treated likely will drive cost trends for antineoplastic enzyme inhibitors.
Tamra Wade
Advertisement
Articles by Tamra Wade
The proportion of Americans diagnosed with Alzheimer's disease (AD) is projected to increase almost 2-fold over the next couple of decades due to size of the Baby Boom generation compared with the total US population.
Advertisement
Latest Updated Articles
- Drug Utilization Patterns in Patients With Alzheimer's Disease
Published: April 6th 2010 | Updated:
- Antineoplastic Enzyme Inhibitor Drug Trend Utilization in the United States
Published: July 16th 2010 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Clinical Manifestations and Prognostic Impact of Anemia in Myelofibrosis
2
Trump Announces Pricing Deals With 9 Drugmakers, Expanding Most-Favored-Nation Drug Pricing Strategy
3
More Dose Adjustments, Similar Outcomes: Ribociclib vs Palbociclib in Practice
4
Understanding Myelofibrosis and the Central Role of JAK Pathway Dysregulation
5